Search

We present a case of a young patient with a symptomatic urachal carcinoma. The patient underwent surgical resection at our department and is now in remission. Urachal cancer must be considered when examining a patient with visible hematuria. [ABSTRACT FROM AUTHOR]

Copyright of Urologie Pro Praxi is the property of SOLEN sro and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

This article summarizes the recent knowledge on the etiology, diagnosis, therapy and complications of urethral injuries. There is much higher overall incidence in males than in females and the most common cause is urethral catheterization and endoscopic examination and procedures. Basic evaluation comprises patient's history, clinical and radiological examination with endoscopy in selected cases. There is a wide scale of treatment options from clinical follow-up, through simple insertion of drainage (catheter, epicystostomy) up to complicated surgical reconstructions. Proper primary managment and further steps are crucial for the final results and consequences for the patient. Due to tiny structure and short course of the female urethra it is focused on male patients, but important comments about differences in the diagnosis and therapy between the genders are mentioned. [ABSTRACT FROM AUTHOR]

Copyright of Urologie Pro Praxi is the property of SOLEN sro and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Urologie Pro Praxi is the property of SOLEN sro and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Introduction: The retroperitoneoscopic approach is advantageous from the point of view of its minimal invasiveness, on the other hand, its disadvantage is the limited space, which can make the actual surgical preparation and treatment of the resection area technically more difficult. Material and methods: In the video presentation, we show the case of a 57-year-old man with abdominal obesity (120 kg, BMI 40), who was diagnosed with a 6 cm tumor on the dorsal side of the convexity of the upper pole of the right kidney based on ultrasonography and subsequent CT examination (RENAL score 9p). The tumor was successfully removed by robotically assisted retroperitoneal resection with minimal blood loss and without intraoperative and postoperative complications. Conclusion: The retroperitoneoscopic approach is advantageous in the case of a kidney-sparing procedure in the presence of dorsally placed kidney tumors, especially in obese patients and patients after previous operations in the peritoneal cavity. [ABSTRACT FROM AUTHOR]

Copyright of Urologie Pro Praxi is the property of SOLEN sro and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Copyright of Czech Urology / Ceska Urologie is the property of Czech Medical Association of JE Purkyne and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Aim: The aim of this study was to evaluate the need for prostate surgery in patients who underwent cystolitholapaxy. Methods: From January 2001 to February 2014, a total of 108 cystolithotripsy procedures (CLT) were performed at our hospital. In all but one case CLT was performed exclusively using transurethral sonotrode or Holmium laser. Benign prostatic hyperplasia (BPH) was determined as the principal diagnosis in 86 men (80%). Twenty five of them (29 %) underwent CLT immediately followed by transurethral prostate surgery. Concurrent prostate surgery was performed in patients with a high risk of recurrence and in those expected to have poor compliance. Outcomes were investigated in a group of 61 patients, who underwent only CLT followed by pharmacological treatment. We retrospectively evaluated the need for prostate surgery in this group. Results: During follow-up, prostate surgery was indicated in 12 patients. Their transrectal ultrasound (TRUS)-measured median prostate volume was 68 ml. The median time from CLT to surgery was 4 months. Recurrent hematuria and retention were the most common indications for prostate surgery. Six patients refused the surgery and three were withdrawn due to their worsening health status. Thirty five patients returning for regular routine follow ups, had no signs of clinical worsening or recurrence of cystolithiasis. Their median follow-up was 4.3 years and the median prostate size was 56 ml. Conclusion: In this study, the newly introduced or modified drug therapy after cystolitholapaxy proved sufficiently effective and a safe alternative to prostate surgery in 40% of men. [ABSTRACT FROM AUTHOR]